In our experience, patients are best served when the all members of the provider team work together and are fully informed. We value your expertise and welcome the opportunity to support you and your patients.

We Work With:
- Psychiatrists
- Therapists
- Psychologists
- Neurologists
- Pain Specialists
- Primary Care Physicians
- Coaches
- Social Workers
Treatments for:
- Depression
- Anxiety
- PTSD
- Migraines & Headaches
- CRPS & Chronic Pain
- Immunity & Resilience
Our Services:
- IV Ketamine
- IV NAD+
- IV Nutrients & Vitamins
- Intranasal Ketamine & NAD+
- IV Glutathione
- Ketamine Assisted Psychotherapy (KAP)
Let us help you support your patients!
We pride ourselves on offering our patients a process that is administratively efficient and clinically rigorous while maintining a high level of personalized care and attention.
WE CAN HELP
Refer Your Patient To Us
If you are a doctor or therapist with a patient you think could benefit from Combination Infusion Therapy, then please submit our referral form.
Latest Science & Research
Ketamine for Unipolar and Bipolar Depression
Due to unmet clinical needs for efficient drugs with a rapid onset of antidepressant effects, we aimed to evaluate the efficacy of single-dose ketamine in different subgroups of patients with major depression and establish whether repeated ketamine administration could be a viable strategy to maintain treatment gains.
Read MorePsychedelic Psychiatry’s Brave New World
After a legally mandated, decades-long global arrest of research on psychedelic drugs, investigation of psychedelics in the context of psychiatric disorders is yielding exciting results.
Read MoreNAD+ in Aging: What It Is & Why You Need It
Rhonda Patrick explains what NAD+, why it is so important for aging and why it declines with age. She discusses some of the popular NAD+ boosters like nicotinamide riboside and nicotinamide mononucleotide, what animal and human data says and some concluding thoughts.
Read MoreStudy: Ketamine for Chronic Posttraumatic Stress Disorder (PTSD)
The authors’ previous proof of- concept randomized controlled trial of single-dose intravenous ketamine infusion in individuals with PTSD showed significant and rapid PTSD symptom reduction 24 hours postinfusion.
Read More